-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Li Fengshuang, Director of the Hebei Branch of Xinhua News Agency, Conducts a Research Visit to Guangxiang Pharmaceutical Group
Category:
发布时间：2022-03-16
【概要描述】
On February 24, Li Fengshuang, Director and Party Secretary of the Hebei Branch of Xinhua News Agency, conducted a research visit to Guangxiang Pharmaceutical, a subsidiary of the Cangzhou Bohai New Area Group.
On February 24, Li Fengshuang, Director and Party Secretary of the Hebei Branch of Xinhua News Agency, visited Guangxiang Pharmaceutical, a subsidiary of the Cangzhou Bohai New Area Group, for an inspection. Wu Hengyao, President of the Group, briefed Li Fengshuang (second from left in the front row) and his delegation on the Group’s overall development and the progress of Guangxiang Pharmaceutical’s construction and expansion. Li Fengshuang stated that Shijiazhuang Sihua Pharmaceutical Group has seized the opportunities presented by the coordinated development of the Beijing–Tianjin–Hebei region, proactively forging a new pattern of industrial development, and thereby generating valuable experience in the innovative development of the pharmaceutical industry—experience that is worthy of wider promotion and emulation.
Li Huafeng, a member of the Standing Committee of the CPC Cangzhou Municipal Committee, Secretary of the Party Working Committee and Director of the Management Committee of the Bohai New Area, and Secretary of the CPC Huanghua Municipal Committee, along with Li Fan, a member of the Standing Committee of the CPC Cangzhou Municipal Committee and Head of the Publicity Department (far left), accompanied the inspection tour.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091